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demonstrate product value beyond traditional safety and
efﬁcacy parameters. We researched country-speciﬁc regu-
lations on the use of health outcomes data for product
promotion and compared requirements/guidelines across
countries.
METHODS: We reviewed regulatory documents govern-
ing the promotion of medicines and code of practice 
documents on the enforcement of promotion guidelines.
Country-speciﬁc examples of promotional material were
collected via journal publications, electronic search and
through contact with the pharmaceutical manufacturer.
RESULTS: Regulations from 15 countries and ﬁve
regions (North America, Europe, Eastern Europe, Asia
and Latin America) were collected. The major distinc-
tions between countries are speciﬁc guidelines on the use
of health outcomes data, the ability to use qualiﬁed data
without prior approval, the level of substantiation
required for promotional use and direct-to-consumer
advertising.
CONCLUSIONS: Regulations regarding the use of health
outcomes data for product promotion are often combined
with safety and efﬁcacy guidelines. There is, however,
movement within regulatory bodies to speciﬁcally address
the use of health outcomes data. Understanding the reg-
ulation and use of health outcomes data for promotional
purposes is useful for global pharmaceutical companies
in developing a comprehensive campaign to demonstrate
product value.
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Health care costs continue to escalate. Prescription 
medications are a large contributor to both the cost and
waste of resources.
OBJECTIVES: This study investigated the number and
type of prescription drugs discarded by a nursing home.
METHODS: Nursing records of prescription drugs dis-
carded throughout ﬁscal year 2001 were analyzed. This
pilot study of one long-term, 143 bed nursing home in a
Southeastern state gives a descriptive baseline and esti-
mate of destroyed prescriptions. The number of drugs 
and associated patients, prescription names, and reasons
for destruction were categorized and analyzed. To 
enable analysis, a systematic categorization of drugs was
created.
RESULTS: Over an eleven-month period, there were
2220 prescribed drugs discarded on 227 patients. Most
of the patients (74%) in this study had between one and
eight of their prescribed drugs destroyed during this time
period. However, 27 patients (14%) had between 20 and
48 prescribed drugs discarded during this same time
period. Discarded drugs were most often for medical con-
dition categories of acute illness (17%), cardio-vascular
(17%), daily needs such as nutritional support (16%),
chronic illness (13%), and mental health (11%). The
most common reasons for destruction were medication
discontinued (51%) and patient expired (20%). This
study substantiates that many prescribed drugs are dis-
carded each month, and it is not uncommon for multiple
discards per patient.
CONCLUSIONS: Nearly half (46%) of the prescribed
drugs to nursing home residents are for long-term medical
care and maintenance, such as cardio-vascular and other
chronic illnesses and nutritional support and other per-
sonal hygiene. This study suggests that prescriptions
should be initially ﬁlled for shorter periods of time to
ensure patient compatibility and effectiveness. Also, it
appears that it would be cost effective to have pharma-
cists dispense drugs from larger vials and to repackage
already prescribed drugs.
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OBJECTIVES: Lack of knowledge is often attributed to
problematic practice by non-professional drug sellers.
Most community pharmacies in Thailand are staffed 
by non-professionals who play dual roles of prescribing
and dispensing. Training courses have been offered by
government agencies attempting to improve quality of
care by providing knowledge to drug sellers. This paper
is part of a study to evaluate effects of multiple inter-
ventions on drug seller behavior. It aims to assess effects
of training on knowledge and practice, and examine
whether practice follows knowledge, using watery diar-
rhea in children under ﬁve as tracer condition.
METHODS: A control-intervention and pre-post design
was used. Eight districts in Bangkok were selected and
matched into four pairs. Districts in each pair were ran-
domly assigned as control and intervention districts.
Seventy-eight community pharmacies were selected ran-
domly from the districts. A training program, emphasiz-
ing case management for diarrhea in children, was offered
to pharmacy staffers in the intervention group. Knowl-
edge was evaluated using open-ended questionnaire 
interviews. Dispensing practices were assessed by two
simulated client surveys. The interviews and surveys were
conducted twice—before and after training.
RESULTS: Pharmacies in both groups responded to the
case with few questions and little advice. Dispensing of
ORS only was found in 6.9 and 4.7% of the encounters
before training for the control and intervention groups
respectively. After the training, it was dispensed in 2.3%
of the encounters in the control and 3.5% in the inter-
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vention group. Anti-diarrheal and anti-microbial drugs
were dispensed in over 90% of the encounters, sometimes
with ORS. Slight improvement in knowledge was seen 
on some aspects after training. However, while ORS-only
was dispensed in fewer than 10% of encounters, around
20% of interviewees indicated they would dispense only
ORS for such case.
CONCLUSIONS: Despite slight improvement of knowl-
edge on some aspects of case management after training,
the program failed to improve practice. Better knowledge
does not necessarily lead to better practice.
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The formulary decision-making (FDM) process involves
many factors that must be considered in order to deter-
mine whether a speciﬁc drug product should be placed on
a formulary. Still, the frequency of use, and the need for
more information of the factors used in FDM is unknown
at this time.
OBJECTIVES: The objectives of this study were to iden-
tify: (1) which outcome measures, pharmacoeconomic
methodologies, and sources of information are used in the
FDM process, and (2) areas in which formulary decision-
makers require more information.
METHODS: A mail survey, based on the literature and
two focus groups held with pharmacists involved in
FDM, was developed in the summer of 2000. The ﬁnal
survey was mailed to 40 registrants to a FDM conference
(before the conference was held) and to 25 other phar-
macists involved in FDM in Atlantic Canada. Respon-
dents were asked to rate their organization’s use and their
personal need for more information of 27 different
factors, tools, and techniques. Data analysis was per-
formed using SumQuest Survey Software, v. 7.0. and JMP,
v. 3.2.1.
RESULTS: Thirty-nine of the 64 (60.9%) useable surveys
were completed and returned. Out of 14 outcome 
measures considered, relative efﬁcacy of the drugs was
identiﬁed as being the most frequently used, while
quality-adjusted life years was identiﬁed as being the least
frequently used. Cost-effectiveness analysis was identiﬁed
as being the most commonly used pharmacoeconomic
technique, while cost-consequence analysis was identiﬁed
as being the least frequently used. Cost-consequence
analysis was identiﬁed by the respondents as being their
single greatest learning need.
CONCLUSIONS: Traditional outcome measures such as
relative efﬁcacy and cost of the drug still appear to be the
main factors used in FDM in Atlantic Canada. The ﬁnd-
ings have provided an insight into the FDM process and
have identiﬁed topics for future continuing education
events.
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In response to increasing prescription costs, managed care
plans are adopting multi-tiered plans that shift medica-
tion costs to the consumer.
OBJECTIVE: To examine the impact of 2 and 3 tiered
plans on patient attitudes and behavior of individuals
with chronic diseases.
METHODS: Quasi-experimental pre-post with compari-
son group design was used for a sample with hyperten-
sion, dylipidemia, arthritis, GERD or diabetes. General
attitudes about formulary medications, factors affecting
the decision to switch to formulary medications and the
willingness-to-pay for non-formulary medications were
obtained from a mail survey administered in the pre
period. Intervention group included members whose
employer converted from a 2-tier to a 3-tier beneﬁt (n =
5,711). Comparison groups included members whose
employer remained in a 2-tier (n = 715) or 3-tier beneﬁt
(n = 1,707). Maximum likelihood estimates from a
repeated measures model were used to examine changes
in formulary compliance controlling for demographics,
health status, diseases, plan type and attitudes. Formulary
compliance rate (pre- versus post- intervention).
RESULTS: Formulary compliance showed a negligible
increase over time in individuals whose plans did not
change. Intervention group experienced a 5.6% increase
in formulary compliance rate (p < .0001). However their
baseline rates were 13% lower than their counterparts in
2-tier plans. Attitudinal measures had no effect on for-
mulary compliance rates. Individuals over 65 years and
those under 25 years were respectively 4.0% and 7.5%
more formulary compliant than those between 25–64
years. Differences existed by disease state: diabetics were
6.9% more compliant, while arthritics (2.8%), hyperten-
sives (2.5%), and members with GERD (6.3%) were less
formulary compliant.
CONCLUSIONS: 3 tier plans can improve formulary
compliance rates of individuals with chronic diseases.
Patient attitudes had no impact on formulary compliance.
Future research should investigate how 3-tier beneﬁts
inﬂuence medical resource utilization.
